Is Bluebird Bio, Inc. (blue) Worth A Look?

Discussion in 'Investment Charts' started by longtermbull, Dec 8, 2017.

  1. longtermbull

    longtermbull Administrator Staff Member

    Joined:
    Nov 2016
    Posts:
    1,210
    Likes Received:
    20
  2. JR Ewing

    JR Ewing Super Moderator Staff Member

    Joined:
    Feb 2014
    Posts:
    4,950
    Likes Received:
    39
    Absolutely. I sold 10 of my last 20 shares yesterday well above $200, so it's a little hot right now. But it's a very good company with excellent drugs in their pipelines.

    I will likely add to my position again when it cools off. I've been in and out of this one over the last couple of years, and when I last took a new position here in late June, it was trading just over $100. So it's had a big runup in a short time for a multi-billion dollar company.
     
  3. longtermbull

    longtermbull Administrator Staff Member

    Joined:
    Nov 2016
    Posts:
    1,210
    Likes Received:
    20
    Looks like the buyers have been chipping away and then the shares finally spiked prompting a bout of profit taking - potentially an interesting buy on weakness as you say :)
     
  4. JR Ewing

    JR Ewing Super Moderator Staff Member

    Joined:
    Feb 2014
    Posts:
    4,950
    Likes Received:
    39
  5. JR Ewing

    JR Ewing Super Moderator Staff Member

    Joined:
    Feb 2014
    Posts:
    4,950
    Likes Received:
    39
    Some analysts have set price targets above $300 on it in light of the latest drug info.
     
  6. Chartman

    Chartman Senior Investor

    Joined:
    Sep 2017
    Posts:
    401
    Likes Received:
    6
    Short term pull back JR? Time to start accumulating stock?
     
  7. JR Ewing

    JR Ewing Super Moderator Staff Member

    Joined:
    Feb 2014
    Posts:
    4,950
    Likes Received:
    39
    I'll probably be buying a little more of it soon.
     
  8. gowiththeflow

    gowiththeflow Senior Investor

    Joined:
    Jul 2017
    Posts:
    567
    Likes Received:
    8
    That is quite a fall from the recent spike - any underlying issues came to light since the price spiked or simply profit taking?
     
  9. JR Ewing

    JR Ewing Super Moderator Staff Member

    Joined:
    Feb 2014
    Posts:
    4,950
    Likes Received:
    39
    These biotechs are like that - when they get a drug approval or other good news, most of them spike up dramatically, then tend to fall back down a fair amount.

    They're very volatile - particularly the smaller ones that may be as little as 7 figures in market cap and that often trade at very low prices.

    I tend to own many of these biotechs and in small amounts - when the news is bad, they're known to fall as much as 70-80% overnight in some cases. Diversification and careful handling of these is essential if you're going to play with them.
     
  10. Chartman

    Chartman Senior Investor

    Joined:
    Sep 2017
    Posts:
    401
    Likes Received:
    6
    Yes, the short term spike is common and then profit takers come in and the process of researching the future potential starts. If there really is anything behind this new development then the shares will start to pick up again - very soon in my opinion.
     
Tags:

Share This Page